# Texas Community Bancshares, Inc.: financial statements, quarterly

TCBS · Nasdaq · CIK 1849466 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tcbs.md) · [Financials](/companies/tcbs/financials.md) · [Filings](/companies/tcbs/filings.md) · [Insiders](/companies/tcbs/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/tcbs/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $k | [2,132](/filings/0001558370-24-015518.md) | [2,382 d](/filings/0001558370-25-003827.md) | [2,455](/filings/0001558370-25-007569.md) | [2,498](/filings/0001558370-24-012078.md) | [2,489](/filings/0001558370-24-015518.md) | [2,460 d](/filings/0001558370-25-003827.md) | [2,306](/filings/0001558370-25-007569.md) | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [117](/filings/0001558370-24-015518.md) | [(66.0) d](/filings/0001558370-25-003827.md) | [(708)](/filings/0001558370-25-007569.md) | [50.0](/filings/0001558370-25-010760.md) | [88.0](/filings/0001104659-25-108476.md) | [94.0 d](/filings/0001104659-26-034560.md) | [106](/filings/0001104659-26-057280.md) | [144](/filings/0001104659-26-094088.md) | [86.0](/filings/0001104659-25-108476.md) | [186 d](/filings/0001104659-26-034560.md) | [119](/filings/0001104659-26-057280.md) | [177](/filings/0001104659-26-094088.md) |
| Net income | $k | [456](/filings/0001558370-24-015518.md) | [(332) d](/filings/0001558370-25-003827.md) | [(2,685)](/filings/0001558370-25-007569.md) | [348](/filings/0001558370-25-010760.md) | [515](/filings/0001104659-25-108476.md) | [517 d](/filings/0001104659-26-034560.md) | [643](/filings/0001104659-26-057280.md) | [678](/filings/0001104659-26-094088.md) | [680](/filings/0001104659-25-108476.md) | [841 d](/filings/0001104659-26-034560.md) | [836](/filings/0001104659-26-057280.md) | [970](/filings/0001104659-26-094088.md) |
| Diluted EPS | $ per share | [0.15](/filings/0001558370-24-015518.md) | not reported | [(0.89)](/filings/0001558370-25-007569.md) | [0.12](/filings/0001558370-25-010760.md) | [0.17](/filings/0001104659-25-108476.md) | not reported | [0.22](/filings/0001104659-26-057280.md) | [0.23](/filings/0001104659-26-094088.md) | [0.24](/filings/0001104659-25-108476.md) | not reported | [0.31](/filings/0001104659-26-057280.md) | [0.35](/filings/0001104659-26-094088.md) |
| Basic EPS | $ per share | [0.15](/filings/0001558370-24-015518.md) | not reported | [(0.90)](/filings/0001558370-25-007569.md) | [0.12](/filings/0001558370-25-010760.md) | [0.18](/filings/0001104659-25-108476.md) | not reported | [0.22](/filings/0001104659-26-057280.md) | [0.24](/filings/0001104659-26-094088.md) | [0.25](/filings/0001104659-25-108476.md) | not reported | [0.32](/filings/0001104659-26-057280.md) | [0.37](/filings/0001104659-26-094088.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $m | [437](/filings/0001558370-23-018300.md) | [452](/filings/0001558370-25-003827.md) | [464](/filings/0001558370-24-008131.md) | [452](/filings/0001558370-24-012078.md) | [446](/filings/0001558370-24-015518.md) | [443](/filings/0001104659-26-034560.md) | [442](/filings/0001558370-25-007569.md) | [444](/filings/0001558370-25-010760.md) | [439](/filings/0001104659-25-108476.md) | [430](/filings/0001104659-26-094088.md) | [430](/filings/0001104659-26-057280.md) | [444](/filings/0001104659-26-094088.md) |
| Total liabilities | $m | [383](/filings/0001558370-23-018300.md) | [398](/filings/0001558370-25-003827.md) | [412](/filings/0001558370-24-008131.md) | [400](/filings/0001558370-24-012078.md) | [393](/filings/0001558370-24-015518.md) | [391](/filings/0001104659-26-034560.md) | [389](/filings/0001558370-25-007569.md) | [391](/filings/0001558370-25-010760.md) | [386](/filings/0001104659-25-108476.md) | [376](/filings/0001104659-26-094088.md) | [376](/filings/0001104659-26-057280.md) | [389](/filings/0001104659-26-094088.md) |
| Shareholders' equity | $m | [53.3](/filings/0001558370-24-015518.md) | [53.7](/filings/0001104659-26-034560.md) | [51.5](/filings/0001558370-25-010760.md) | [51.8](/filings/0001104659-25-108476.md) | [52.7](/filings/0001104659-25-108476.md) | [52.1](/filings/0001104659-26-094088.md) | [52.8](/filings/0001104659-26-094088.md) | [52.9](/filings/0001104659-26-094088.md) | [53.5](/filings/0001104659-25-108476.md) | [53.8](/filings/0001104659-26-094088.md) | [54.2](/filings/0001104659-26-094088.md) | [55.2](/filings/0001104659-26-094088.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [1,471 d](/filings/0001558370-24-015518.md) | [(682) d](/filings/0001558370-25-003827.md) | [641](/filings/0001558370-25-007569.md) | [404 d](/filings/0001558370-25-010760.md) | [816 d](/filings/0001104659-25-108476.md) | [80.0 d](/filings/0001104659-26-034560.md) | [(1,533)](/filings/0001104659-26-057280.md) | [1,007 d](/filings/0001104659-26-094088.md) | [1,591 d](/filings/0001104659-25-108476.md) | [302 d](/filings/0001104659-26-034560.md) | [1,608](/filings/0001104659-26-057280.md) | [1,371 d](/filings/0001104659-26-094088.md) |
| Capital expenditure | $k | [1,036 d](/filings/0001558370-24-015518.md) | [1,241 d](/filings/0001558370-25-003827.md) | [986](/filings/0001558370-25-007569.md) | [195 d](/filings/0001558370-25-010760.md) | [11.0 d](/filings/0001104659-25-108476.md) | [9.0 d](/filings/0001104659-26-034560.md) | [28.0](/filings/0001104659-26-057280.md) | [185 d](/filings/0001104659-26-094088.md) | [39.0 d](/filings/0001104659-25-108476.md) | [142 d](/filings/0001104659-26-034560.md) | [1,786](/filings/0001104659-26-057280.md) | [585 d](/filings/0001104659-26-094088.md) |
| Dividends paid | $k | [97.0 d](/filings/0001558370-24-015518.md) | [103 d](/filings/0001558370-25-003827.md) | [128](/filings/0001558370-25-007569.md) | [127 d](/filings/0001558370-25-010760.md) | [125 d](/filings/0001104659-25-108476.md) | [124 d](/filings/0001104659-26-034560.md) | [123](/filings/0001104659-26-057280.md) | [119 d](/filings/0001104659-26-094088.md) | [118 d](/filings/0001104659-25-108476.md) | [233 d](/filings/0001104659-26-034560.md) | [143](/filings/0001104659-26-057280.md) | [173 d](/filings/0001104659-26-094088.md) |
| Share repurchases | $k | [966 d](/filings/0001558370-24-015518.md) | [623 d](/filings/0001558370-25-003827.md) | [154](/filings/0001558370-25-007569.md) | [430 d](/filings/0001558370-25-010760.md) | [418 d](/filings/0001104659-25-108476.md) | [576 d](/filings/0001104659-26-034560.md) | [495](/filings/0001104659-26-057280.md) | [846 d](/filings/0001104659-26-094088.md) | [1,006 d](/filings/0001104659-25-108476.md) | [816 d](/filings/0001104659-26-034560.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [3,029](/filings/0001558370-23-018300.md) | [3,089](/filings/0001558370-24-008131.md) | [3,132](/filings/0001558370-24-012078.md) | [3,055](/filings/0001558370-24-015518.md) | [3,013](/filings/0001558370-25-007569.md) | [3,007](/filings/0001558370-25-010760.md) | [3,007](/filings/0001104659-25-108476.md) | [2,966](/filings/0001104659-26-057280.md) | [2,923](/filings/0001104659-26-094088.md) | [2,866](/filings/0001104659-25-108476.md) | [2,737](/filings/0001104659-26-057280.md) | [2,743](/filings/0001104659-26-094088.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 2,872,727 at 2026-08-07, from the cover of the [10-Q filed 2026-08-11](/filings/0001104659-26-094088.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.